Overview
- 159 inspections across 143 sites are on record.
- 164 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-10-09.
At a glance
Inspections
159
Sites
143
Observations
164
Career since
Jan 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biogen International GmbH | 9 Oct 2025 | Human Drugs | On file |
| Lonza AG | 4 Apr 2025 | Human Drugs | On file |
| Lonza AG | 4 Apr 2025 | Human Drugs | On file |
| Akeso Biopharma Co., Ltd. | 4 Mar 2025 | Human Drugs | On file |
| Allergan Pharmaceuticals Ireland | 30 Jan 2025 | Human Drugs | On file |
Sites inspected
Biogen International GmbHLuterbach, Switzerland1 insp.
Lonza AGVisp, Switzerland1 insp.
Lonza AGVisp, Switzerland1 insp.
Akeso Biopharma Co., Ltd.Zhongshan, China1 insp.
Allergan Pharmaceuticals IrelandWestport, Ireland1 insp.
Co-investigators
Investigators who share inspections with this person.
Kathleen B Swat15 shared
Jeffery L Sumter9 shared
Adree N Anderson8 shared
Melissa D Ray7 shared
Edward E Lockwood6 shared
Sherry G Bous6 shared
Jeanne M Fringer5 shared
Steven D Kehoe5 shared
Samuel K Gibbons5 shared
Eric M Mueller5 shared
Full investigator report
Get the verbatim findings behind Thuy T Nguyen's 164 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site